US2023272344A1PendingUtilityA1
Compositions and methods for performing magnetibuoyant separations
Est. expiryApr 30, 2036(~9.8 yrs left)· nominal 20-yr term from priority
C12N 5/0637C12N 5/0647A61K 35/28B01J 20/06B01J 20/10B01J 20/103B01J 20/24B01J 20/28007B01J 20/28009B01J 20/28021B01J 20/3204B01J 20/3217B01J 20/3236B01J 20/328B01J 20/3289B01J 20/3293B03C 1/015B03C 1/28C07K 16/2812C12N 15/1013G01N 33/54326G01N 33/54333G01N 33/54346G01N 33/552B03C 2201/18B03C 2201/26C12M 47/04
72
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The methods of the invention employ targeted magnetic particles, preferably targeted nanomagnetic particles, and targeted buoyant particles such as buoyant microparticles and microbubbles. Among the benefits of the invention is the ability to combine targeted magnetic particles with differentially targeted buoyant particles to achieve separation of two or more specifically cell targeted populations during the same work flow.
Claims
exact text as granted — not AI-modifiedWhat is claimed is:
1 . A kit for separating at least one target biomolecule species from a biological sample, the kit comprising:
(a) a composition that comprises a targeted magnetic particle species, optionally a targeted nanomagnetic particle species, that targets a first biomolecule species of interest; (b) a composition that comprises a targeted buoyant particle species, optionally a targeted buoyant microparticle species, optionally a targeted buoyant microbubble species, that targets a second biomolecule species of interest, which composition targets a different biomolecule species as compared to that targeted by the composition comprising the targeted magnetic particle species; and (c) instructions for separating the at least one target biomolecule species using the targeted magnetic particle species and the targeted buoyant particle species.
2 . The kit according to claim 1 , wherein the kit comprises a plurality of targeted magnetic particle species, wherein the biomolecule species of interest targeted by each targeted magnetic particle species is different from other biomolecule species of interest targeted by other targeted magnetic particle species and targeted buoyant microparticle species in the kit, wherein the different targeted magnetic particle species are in the same or different compositions in the kit.
3 . The kit according to claim 1 , wherein the kit comprises a plurality of targeted buoyant particle species, wherein the biomolecule species of interest targeted by each targeted buoyant particle species is different from other biomolecule species of interest targeted by other targeted magnetic particle species and targeted buoyant particle species in the kit, wherein the different targeted buoyant particle species are in the same or different compositions in the kit.
4 . The kit according to claim 1 , wherein the targeted magnetic particle species is a targeted nanomagnetic particle species that comprises:
(i) a magnetic core particle; (ii) a glass layer encapsulating the magnetic core particle; (iii) a protein/polymer composite layer bound to the glass layer; and (iv) a targeting moiety that targets the first biomolecule species of interest and comprises one member of a bioaffinity ligand pair bound to the protein/polymer composite layer.
5 . The kit according to claim 4 , wherein the magnetic core particle of the targeted nanomagnetic particle species comprises magnetite (Fe 3 O 4 ) crystal, optionally wherein the magnetite crystals have a diameter ranging from about 5 nm to about 300 nm.
6 . The kit according to claim 4 , wherein the glass layer of the targeted nanomagnetic particle species is a silane layer formed from organofunctional alkoxysilane molecules, optionally organofunctional alkoxysilane molecules that comprise a couplable end group, optionally a couplable end group selected from the group consisting of an amino, sulphydryl, carboxyl, and hydroxyl end group.
7 . The kit according to claim 4 , wherein the protein/polymer composite layer of the targeted nanomagnetic particle species is covalently bound to the glass layer, optionally wherein the protein/polymer composite layer is comprised of serum albumin, optionally bovine or human serum albumin, dextran or casein and wherein optionally the protein/polymer composite layer is permanently bound by heating the composition from about 45° C. to about 85° C.Join the waitlist — get patent alerts
Track US2023272344A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.